Stay updated on De-Escalated Radiation + Nivolumab in P16+ Oropharynx Cancer Clinical Trial
Sign up to get notified when there's something new on the De-Escalated Radiation + Nivolumab in P16+ Oropharynx Cancer Clinical Trial page.

Latest updates to the De-Escalated Radiation + Nivolumab in P16+ Oropharynx Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 has been added to the page. Earlier entries, including a government funding notice and Revision: v3.4.1, appear to have been removed.SummaryDifference0.3%

- Check21 days agoChange DetectedAdded a site-wide notice about government funding status and NIH Clinical Center operations, and updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check28 days agoChange DetectedAdditions: Show glossary; Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0. Deletions: Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4. These are UI and metadata updates rather than changes to core study content.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision updated to v3.3.4; the previous revision v3.3.3 was removed.SummaryDifference0.0%

- Check64 days agoChange DetectedAdded Locations: Georgia, Oregon, Pennsylvania, and updated page revision to v3.3.3. Removed Georgia Locations, Oregon Locations, and Pennsylvania Locations in revision v3.3.2.SummaryDifference0.3%

- Check92 days agoChange DetectedRevision: v3.3.2 appears on the page, replacing v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to De-Escalated Radiation + Nivolumab in P16+ Oropharynx Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the De-Escalated Radiation + Nivolumab in P16+ Oropharynx Cancer Clinical Trial page.